Teva Pharmaceutical Industries
TEVA----
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Teva Pharmaceutical Industries(TEVA) predict that the Revenue is 3.982 B (+2.34%), Beat estimate;the EBIT is 956 M (+1.06%), Beat estimate;the EPS is 0.31 (+72.22%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
3.98B2.34%
3.79B2.67%
+0.19B5.01%
EBITExceed expectations
0.96B1.06%
0.85B9.63%
+0.10B10.69%
EPSExceed expectations
0.3172.22%
0.16697.27%
+0.143179.49%
Upcoming earnings report - FY2026 Q2 Earning Release
Available dateJul 29, 2026
Estimate Revenue4.037 B
Estimate EBIT326.99 M
Estimate EPS-0.1457
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf